Bellerophon Therapeutics, Inc.Bellerophon Therapeutics, Inc.Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪256.89 K‬USD
‪11.15 M‬
Beta (1Y)
1.03

About Bellerophon Therapeutics, Inc.


CEO
Craig R. Jalbert
Headquarters
Warren
Founded
2009
FIGI
BBG007X1TKD5
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BLPH is 0.0100 USD — it has decreased by −52.38% in the past 24 hours. Watch Bellerophon Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bellerophon Therapeutics, Inc. stocks are traded under the ticker BLPH.
BLPH stock has fallen by −75.00% compared to the previous week, the month change is a −72.97% fall, over the last year Bellerophon Therapeutics, Inc. has showed a −69.23% decrease.
BLPH reached its all-time high on Feb 27, 2015 with the price of 193.8000 USD, and its all-time low was 0.0290 USD and was reached on Nov 17, 2023. View more price dynamics on BLPH chart.
See other stocks reaching their highest and lowest prices.
BLPH stock is 110.00% volatile and has beta coefficient of 1.03. Track Bellerophon Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bellerophon Therapeutics, Inc. there?
Yes, you can track Bellerophon Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Bellerophon Therapeutics, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
No, BLPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BLPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bellerophon Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bellerophon Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bellerophon Therapeutics, Inc. stock shows the sell signal. See more of Bellerophon Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.